Augmentin 875/125 mg antibiotic

Augmentin is a widely used antibiotic that combines Amoxicillin and Clavulanic acid. The brand was originally developed by Beecham Group, a British company, which launched the drug in the 1980s. Following several corporate mergers, the brand became part of the SmithKline Beecham portfolio and eventually transitioned to GlaxoSmithKline (GSK) upon its formation in 2000.

GSK, one of the world's largest pharmaceutical companies, remains the ultimate owner and manufacturer of the brand. Due to its global demand, Augmentin is produced in various state-of-the-art manufacturing facilities across the United Kingdom, Europe, and other international locations to supply different regional markets. The packaging shown is for the Greek market, though the product itself is managed by the British multinational parent company.